V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007940 | 190004554 | 1.66 | 72.8 | Adjuvant (A) | 2017-07-28 | 2017-08-01 | Trastuzumab | 02 | Y | TRIAL UNSPECIFIED | 100396252 |
| 190007941 | 190004555 | 0 | 77 | Neo-adjuvant (N) | 2020-12-10 | 2020-12-30 | VINORELBINE | 02 | N | CISPLATIN + FLUOROURACIL | 100353331 |
| 190007946 | 190004556 | 1.77 | 45.1 | Neo-adjuvant (N) | 2016-04-07 | 2016-09-12 | PEMBROLIZUMAB | 01 | N | CAPECITABINE + OXALIPLATIN | 101263361 |
| 190007951 | 190004557 | 0 | 57.2 | Palliative (P) | 2020-06-26 | 2020-06-29 | VAI (Ifos 3g/m2) | 02 | N | FLUOROURACIL + IRINOTECAN | 100006144 |
| 190007959 | 190004558 | 1.58 | 84.1 | Curative (C) | 2017-06-13 | 2017-07-21 | Carboplatin AUC 2 - 5 | null | N | CARBOPLATIN | 100937043 |
| 190007960 | 190004559 | 1.58 | 65.6 | null | 2018-11-22 | 2018-12-13 | Cyclophosphamide + Topotecan | null | null | PACLITAXEL | 101631786 |
| 190007962 | 190004560 | 0 | 21 | null | 2017-06-20 | 2017-11-16 | GEMCITABINE | 02 | N | BEP | 101116804 |
| 190007975 | 190004561 | 1.6 | 46.5 | Palliative (P) | 2017-07-08 | 2017-08-20 | GemCarbo Days 1+8 | 02 | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100532757 |
| 190007978 | 190004562 | 1.77 | 70 | Curative (C) | 2018-07-28 | 2018-10-19 | BEP 5 Day | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 101237920 |
| 190007982 | 190004563 | 1.77 | 98.15 | null | 2019-02-02 | 2019-02-03 | Cisplatin + Radiotherapy | N | N | CARBOPLATIN + ETOPOSIDE | 100965767 |
| 190007985 | 190004564 | 1.75 | 67.4 | null | null | 2017-01-10 | DHAP | N | N | RUCAPARIB | 100952773 |
| 190007990 | 190004565 | 1.47 | 96.5 | Neo-adjuvant (N) | null | 2016-12-10 | Cisplatin | null | null | CISPLATIN | 100363231 |
| 190007991 | 190004566 | 1.9 | 58 | Neo-adjuvant (N) | null | 2019-01-02 | Trabectedin | null | null | CISPLATIN + FLUOROURACIL | 100804907 |
| 190007992 | 190004567 | 1.81 | 50.5 | null | 2016-06-23 | 2016-06-28 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | N | CAPECITABINE + CARBOPLATIN | 100792476 |
| 190007993 | 190004568 | 1.93 | 84.4 | null | 2017-01-15 | 2017-02-03 | Enzalutamide | 02 | null | CISPLATIN + PEMETREXED | 100526904 |
| 190007995 | 190004569 | 1.83 | 108 | null | 2017-01-17 | 2017-01-23 | CISPLATIN + RT | 02 | N | CISPLATIN | 100721617 |
| 190007998 | 190004570 | 1.79 | null | Palliative (P) | 2018-07-02 | 2018-07-07 | Etoposide oral | N | N | PACLITAXEL | 100571457 |
| 190008005 | 190004571 | 1.72 | 98.4 | null | 2018-08-26 | 2018-09-13 | NB HRNBL-1 BUMEL MAT | 02 | N | TRIAL UNSPECIFIED | 100408957 |
| 190008008 | 190004572 | 1.72 | 76.4 | Curative (C) | 2015-12-26 | 2016-06-30 | EW EuroEwing 2012 Arm A VAI | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100549007 |
| 190008022 | 190004574 | 1.79 | 100.25 | Curative (C) | 2016-09-01 | 2017-03-03 | null | N | N | DOCETAXEL | 101794020 |
| 190008029 | 190004575 | 0 | 35.1 | null | 2017-02-13 | 2017-02-14 | EDP | 02 | N | TEMOZOLOMIDE | 100040443 |
| 190008041 | 190004576 | 1.6 | 44.8 | Curative (C) | 2019-01-25 | 2019-01-25 | Cyclophosphamide oral | 02 | N | FEC + DOCETAXEL | 101856265 |
| 190008042 | 190004577 | 1.64 | 106.3 | Palliative (P) | 2017-12-16 | 2018-03-24 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101259588 |
| 190008048 | 190004578 | 1.72 | 106.8 | Palliative (P) | null | 2021-02-09 | Cisplatin | 02 | null | CISPLATIN | 101836772 |
| 190008053 | 190004579 | 0 | 19.4 | Palliative (P) | 2018-11-21 | 2019-05-08 | FLUOROURACIL + IRINOTECAN | null | null | CISPLATIN + GEMCITABINE | 100049858 |
| 190008054 | 190004580 | 1.88 | 80 | Curative (C) | 2015-11-03 | 2016-03-03 | Cisplatin + Radiotherapy | 02 | N | PEMBROLIZUMAB | 100561899 |
| 190008059 | 190004581 | 1.48 | 86.8 | Curative (C) | 2017-08-06 | 2017-12-19 | Capecitabine (21 day) + Irinotecan | 02 | null | CARBOPLATIN + ETOPOSIDE | 101539614 |
| 190008062 | 190004582 | 1.79 | null | Palliative (P) | 2019-08-13 | 2019-08-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100509524 |
| 190008067 | 190004583 | 0 | 8.4 | Neo-adjuvant (N) | 2017-11-11 | 2017-11-19 | NB HRNBL-1 COJEC Ind COURSE B | 02 | null | CISPLATIN + FLUOROURACIL | 100253779 |
| 190008068 | 190004584 | 0 | 21 | Neo-adjuvant (N) | 2018-10-24 | 2018-11-10 | NB BEACON Temoz Irin Bev | 02 | N | PACLITAXEL | 101474207 |
| 190008069 | 190004585 | 1.73 | 53.75 | Neo-adjuvant (N) | null | 2020-05-25 | GemCarbo Days 1+8 | null | null | OCTREOTIDE | 100075619 |
| 190008073 | 190004586 | 1.72 | 62.5 | Palliative (P) | 2021-05-24 | 2021-05-29 | Bevacizumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101006586 |
| 190008079 | 190004587 | 1.55 | 100.8 | Curative (C) | 2020-01-28 | 2020-01-28 | EURAMOS TRIAL | 02 | N | FLUOROURACIL + OXALIPLATIN | 101186131 |
| 190008082 | 190004588 | 1.73 | 64 | Palliative (P) | 2019-12-01 | 2019-12-01 | EW EuroEwing 2012 Arm A/B Zol Acid | 02 | N | CARBOPLATIN + ETOPOSIDE | 101487489 |
| 190008089 | 190004589 | 0 | 31.9 | null | 2017-05-03 | 2017-10-12 | CISPLATIN + GEMCITABINE | 99 | N | CARBOPLATIN + ETOPOSIDE | 101439729 |
| 190008095 | 190004590 | 1.66 | 57.7 | Palliative (P) | 2018-11-02 | 2018-11-22 | Cisplatin 7 day | 02 | N | CISPLATIN | 101435488 |
| 190008101 | 190004591 | 0 | 95.1 | Palliative (P) | 2019-03-21 | 2019-04-04 | MAP + MIFAMURTIDE | 02 | N | CISPLATIN + RT | 100415829 |
| 190008102 | 190004592 | 1.85 | 104.3 | Curative (C) | null | 2019-06-04 | Cisplatin + Doxorubicin | null | null | CISPLATIN + RT | 100272854 |
| 190008104 | 190004593 | 1.55 | 55.4 | Palliative (P) | 2020-06-19 | 2020-07-07 | STS Non-Rhabdo EpSSG 2005 IE | 02 | N | CAPECITABINE + CARBOPLATIN | 100138624 |
| 190008110 | 190004594 | 1.73 | 88 | Neo-adjuvant (N) | 2017-11-02 | 2017-11-05 | EW EuroEwing 2012 Arm B VDC | 02 | N | DOCETAXEL + NINTEDANIB | 100257695 |
| 190008118 | 190004595 | null | 86.6 | Palliative (P) | 2020-11-23 | 2020-11-24 | OST Euramos 1 Closed Trial - M | N | N | CYTARABINE | 100248411 |
| 190008131 | 190004596 | 1.8 | 73 | Palliative (P) | 2018-09-20 | 2018-09-27 | EW EuroEwing 2012 Arm A VAI | 02 | N | NIVOLUMAB | 100286973 |
| 190008135 | 190004597 | null | 98.15 | null | 2017-10-30 | 2018-04-12 | FLUOROURACIL + OXALIPLATIN | 02 | N | TRIAL UNSPECIFIED | 100764551 |
| 190008140 | 190004598 | 1.73 | 51.7 | Palliative (P) | null | 2018-06-25 | Cisplatin | null | null | CISPLATIN | 100822534 |
| 190008141 | 190004599 | 0 | 36 | null | 2018-11-23 | 2018-11-25 | Trabectedin | 02 | null | NIVOLUMAB | 100420955 |
| 190008146 | 190004600 | 0 | 65.6 | Neo-adjuvant (N) | 2018-01-16 | 2018-02-20 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101233068 |
| 190008148 | 190004601 | 0 | 31.4 | Curative (C) | null | 2020-01-28 | EW EuroEwing 2012 Arm A VAI | 01 | N | CARBOPLATIN + DOCETAXEL | 100640897 |
| 190008149 | 190004602 | 1.71 | 48.7 | null | 2017-03-06 | 2017-03-12 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | DOCETAXEL | 101521581 |
| 190008159 | 190004603 | 1.79 | 75.9 | Palliative (P) | 2019-12-14 | 2019-12-25 | ECX | 02 | N | TRIAL UNSPECIFIED | 101102286 |
| 190008170 | 190004604 | 1.55 | 100.25 | Curative (C) | 2017-11-09 | 2017-12-01 | Docetaxel | 02 | N | SUNITINIB | 101093495 |